Page last updated: 2024-10-31

acecainide and Arthritis, Rheumatoid

acecainide has been researched along with Arthritis, Rheumatoid in 1 studies

Acecainide: A major metabolite of PROCAINAMIDE. Its anti-arrhythmic action may cause cardiac toxicity in kidney failure.
N-acetylprocainamide : A benzamide obtained via formal condensation of 4-acetamidobenzoic acid and 2-(diethylamino)ethylamine.

Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.

Research Excerpts

ExcerptRelevanceReference
"Nineteen patients whose arrhythmias were initially suppressed with acetylprocainamide underwent long-term treatment with this drug."3.66Long-term antiarrhythmic therapy with acetylprocainamide. ( Drayer, DE; Kluger, J; Leech, S; Lloyd, V; Reidenberg, MM, 1981)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kluger, J1
Leech, S1
Reidenberg, MM1
Lloyd, V1
Drayer, DE1

Other Studies

1 other study available for acecainide and Arthritis, Rheumatoid

ArticleYear
Long-term antiarrhythmic therapy with acetylprocainamide.
    The American journal of cardiology, 1981, Volume: 48, Issue:6

    Topics: Acecainide; Acetylation; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Arthritis, Rheum

1981